BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang YC, Guo LQ, Chen X, Wang GN, Ni R, Wang MC, Wei FX. The role of death receptor 3 in the biological behavior of hepatocellular carcinoma cells. Mol Med Rep 2015;11:797-804. [PMID: 25370568 DOI: 10.3892/mmr.2014.2858] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
Number Citing Articles
1 Jiang H, Tang W, Song Y, Jin W, Du Q. Induction of Apoptosis by Metabolites of Rhei Radix et Rhizoma (Da Huang): A Review of the Potential Mechanism in Hepatocellular Carcinoma. Front Pharmacol 2022;13:806175. [PMID: 35308206 DOI: 10.3389/fphar.2022.806175] [Reference Citation Analysis]
2 Wang M, Chen D, Xu Y, Qiu M, Jiang X, Xiong Z. Identification and Validation of the lncRNA BACE1-AS as Immune-Related Influencing Factor in Tumorigenesis following Pan-Carcinoma Analysis. J Immunol Res 2021;2021:1589864. [PMID: 34926701 DOI: 10.1155/2021/1589864] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Ye D, Zhou C, Wang S, Deng H, Shen Z. Tumor suppression effect of targeting periostin with siRNA in a nude mouse model of human laryngeal squamous cell carcinoma. J Clin Lab Anal 2019;33:e22622. [PMID: 29978598 DOI: 10.1002/jcla.22622] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
4 Li K, Tian H. Development of small-molecule immune checkpoint inhibitors of PD-1/PD-L1 as a new therapeutic strategy for tumour immunotherapy. J Drug Target 2019;27:244-56. [PMID: 29448849 DOI: 10.1080/1061186X.2018.1440400] [Cited by in Crossref: 55] [Cited by in F6Publishing: 57] [Article Influence: 11.0] [Reference Citation Analysis]